Page 5 - Forefront Analytics News Today

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) dropped 4.8% on Monday . The stock traded as low as $14.85 and last traded at $14.85. 92,072 shares traded hands during trading, a decline of 79% from the average daily volume of 430,712 shares. The stock had previously closed at $15.60. Analyst Ratings […]

Annexon (NASDAQ:ANNX – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a research report issued on Thursday, Benzinga reports. They presently have a $16.00 price target on the stock. Needham & Company LLC’s target price would indicate a potential upside of 167.56% from the stock’s current price. Several […]

Annexon, Inc. (NASDAQ:ANNX – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have issued a report on the […]

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a drop of 8.3% from the February 29th total of 8,640,000 shares. Based on an average trading volume of 2,210,000 shares, […]

Zura Bio (NASDAQ:ZURA – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a research note issued to investors on Monday, Benzinga reports. They presently have a $16.00 price objective on the stock, down from their previous price objective of $17.00. Zura Bio Stock Up 0.4 % NASDAQ:ZURA […]

Nkarta, Inc. (NASDAQ:NKTX – Free Report) – Investment analysts at HC Wainwright lifted their Q1 2024 earnings per share (EPS) estimates for shares of Nkarta in a report released on Monday, March 25th. HC Wainwright analyst E. Bodnar now forecasts that the company will earn ($0.46) per share for the quarter, up from their previous […]

Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $11.09, but opened at $10.80. Nkarta shares last traded at $10.82, with a volume of 70,617 shares trading hands. Analyst Upgrades and Downgrades Several analysts recently weighed in on the stock. Mizuho reduced their […]

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price […]

Nkarta (NASDAQ:NKTX – Get Free Report) had its price target increased by investment analysts at Canaccord Genuity Group from $15.00 to $16.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective indicates a potential upside of 52.53% from the stock’s previous […]

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Equities research analysts at William Blair lifted their Q1 2024 EPS estimates for shares of Fusion Pharmaceuticals in a research report issued to clients and investors on Thursday, March 21st. William Blair analyst A. Hsieh now forecasts that the company will post earnings per share of ($0.39) […]